Endocrine research
Tesamorelin vs Sermorelin
GHRH analogues with different clinical and research histories.
Overview
This comparison separates Tesamorelin and Sermorelin for laboratory reference—not product selection.
Tesamorelin: Tesamorelin is an FDA-approved synthetic GHRH analog designed for HIV-associated lipodystrophy treatment. It provides selective visceral fat targeting with 15-20% visceral fat redu…
Sermorelin: Sermorelin is a synthetic 29-amino acid analog of human growth hormone-releasing hormone that stimulates natural growth hormone production while preserving physiological pulsatile…
Key differences
- Both appear in GLP-1 & metabolic literature, but mechanistic framing differs.
- The useful distinction is research question and receptor context—not relative potency or practical ranking.
Mechanistic differences
Tesamorelin: Tesamorelin is an FDA-approved synthetic GHRH analog designed for HIV-associated lipodystrophy treatment. It provides selective visceral fat targeting with 15-2…
Sermorelin: Sermorelin is a synthetic 29-amino acid analog of human growth hormone-releasing hormone that stimulates natural growth hormone production while preserving phys…
Pharmacology
Tesamorelin: Subcutaneous injection provides optimal bioavailability for GHRH receptor binding and pulsatile GH release stimulation, selectively targeting visceral adipose t…
Sermorelin: Subcutaneous injection provides optimal bioavailability for binding GHRH receptors, stimulating pulsatile GH release while maintaining hypothalamic-pituitary ax…
Research focus
Tesamorelin: GLP-1 & metabolic: Tesamorelin is an FDA-approved synthetic GHRH analog designed for HIV-associated lipodystrophy treatment. It provides selective visceral fat targeting…
Sermorelin: GLP-1 & metabolic: Sermorelin is a synthetic 29-amino acid analog of human growth hormone-releasing hormone that stimulates natural growth hormone production while preser…
At a glance
Practical differentiation
- AXIOM does not provide dosing, administration, or protocol guidance.
- Catalogue links appear only where AXIOM lists a research-use product.
- Reference-only compounds remain comparison terms without implying availability.
References
- pubmed.ncbi.nlm.nih.gov/18057338/
- pubmed.ncbi.nlm.nih.gov/22869065/
- pubmed.ncbi.nlm.nih.gov/20101189/
- pubmed.ncbi.nlm.nih.gov/31611038/
- pubmed.ncbi.nlm.nih.gov/41545261/
- pubmed.ncbi.nlm.nih.gov/2877535/
- pubmed.ncbi.nlm.nih.gov/8772599/
- pubmed.ncbi.nlm.nih.gov/9141536/
FAQ
Does this page recommend Tesamorelin or Sermorelin?
No. It is an editorial comparison for research context only.
Does AXIOM provide protocol guidance?
No. Protocol and dosing decisions belong with qualified laboratory teams and source literature.